The United Bio-Technology (Hengqin) Co., Ltd.
Registry sponsor category
Industry
- Other names
- The United Bio-Technology (Hengqin) Co., Ltd.
- Company name
- The United Bio-Technology (Hengqin) Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (12)
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
- A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone（UNIGUIDE-1）
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
- Study of UBT37034 Injection
- UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
- UBT251 Injection Phase II Clinical Study (CKD)
- UBT251 Injection Phase II Study (Overweight or Obesity)
- UBT251 Injection Phase Ⅲ Study (OSA-NPAP)
- UBT251 Injection Phase Ⅲ Study (OSA-PAP)
- UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)